Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADIAL PHARMACEUTICALS, INC. | Director | Common Stock | 1.26M | $530K | $0.42 | May 23, 2023 | Direct |
Sysorex, Inc. | Director | Common Stock | 75K | Sep 3, 2021 | Direct | ||
ADIAL PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 50K | May 23, 2023 | Direct | ||
Avalon GloboCare Corp. | Director | Stock Option (right to buy) | 8K | Jan 1, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADIL | ADIAL PHARMACEUTICALS, INC. | May 23, 2023 | 2 | $0 | 4 | May 25, 2023 | Director |
ADIL | ADIAL PHARMACEUTICALS, INC. | Dec 30, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
ADIL | ADIAL PHARMACEUTICALS, INC. | Aug 22, 2022 | 1 | $0 | 4 | Aug 23, 2022 | Director |
ADIL | ADIAL PHARMACEUTICALS, INC. | Feb 23, 2022 | 1 | $0 | 4 | Feb 25, 2022 | Chief Executive Officer, Director |
ADIL | ADIAL PHARMACEUTICALS, INC. | Nov 29, 2021 | 2 | $55.1K | 4 | Dec 1, 2021 | Chief Executive Officer, Director, 10%+ Owner |
SYSX | Sysorex, Inc. | Sep 3, 2021 | 1 | $0 | 4 | Sep 10, 2021 | Director |
SYSX | Sysorex, Inc. | Sep 3, 2021 | 0 | $0 | 3 | Sep 10, 2021 | Director |
ALBT | Avalon GloboCare Corp. | Jan 1, 2021 | 3 | $0 | 4 | Mar 8, 2023 | Director |